Clinical trial
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
NCT00175383 · University of British Columbia, Other · Unknown status
Key facts
| NCT number | NCT00175383 |
|---|---|
| Title | Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer |
| Official title | A Randomized Trial of Short Versus Long Acting LHRH Agonist Preparation Prior to Transperineal Implantation of the Prostate |
| Lead sponsor | University of British Columbia, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | luteinizing hormone-releasing hormone (LHRH) short acting or long acting |
| Enrollment | 100 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 11, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: